BOK Financial Private Wealth’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31K Hold
218
﹤0.01% 405
2025
Q4
$1.56K Hold
218
﹤0.01% 436
2025
Q3
$2.33K Hold
218
﹤0.01% 361
2025
Q2
$2.11K Hold
218
﹤0.01% 403
2025
Q1
$3.25K Sell
218
-72
-25% -$1.11K ﹤0.01% 447
2024
Q4
$4.33K Sell
290
-100
-26% -$1.63K ﹤0.01% 410
2024
Q3
$7.46K Sell
390
-10
-3% -$207 ﹤0.01% 412
2024
Q2
$8.28K Hold
400
﹤0.01% 379
2024
Q1
$7.52K Buy
400
+110
+38% +$1.89K ﹤0.01% 380
2023
Q4
$4.18K Hold
290
﹤0.01% 409
2023
Q3
$5.04K Hold
290
﹤0.01% 342
2023
Q2
$6.04K Hold
290
﹤0.01% 326
2023
Q1
$6.82K Hold
290
﹤0.01% 351
2022
Q4
$8.1K Buy
290
+10
+4% +$256 ﹤0.01% 325
2022
Q3
$7K Hold
280
﹤0.01% 337
2022
Q2
$9K Buy
+280
New +$9.81K ﹤0.01% 337

Other funds holding OGN

BOK Financial Private Wealth's OGN Position: Q1 2026 in Review

BOK Financial Private Wealth held its Organon & Co (OGN) position steady in Q1 2026 at 218 shares worth $1.31K. The position accounts for ﹤0.01% of the portfolio, ranked #405.

BOK Financial Private Wealth first reported a position in OGN in Q2 2022 and has held it in 16 quarters since. The position peaked at $9K in Q2 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • BOK Financial Private Wealth held 218 shares of Organon & Co worth $1.31K as of Q1 2026.
  • BOK Financial Private Wealth left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of BOK Financial Private Wealth's portfolio in Q1 2026, its #405 holding.
  • BOK Financial Private Wealth first reported a position in Organon & Co in Q2 2022 and has held it in 16 quarters since.
  • BOK Financial Private Wealth's Organon & Co position peaked at $9K in Q2 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on BOK Financial Private Wealth's 13F filing for Q1 2026, filed 12 May 2026.